Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke

During the past decades, candidate drugs that have shown neuroprotective efficacy in the preclinical setting have failed in clinical stroke trials. As a result, no treatment for stroke based on neuroprotection is available today. The activation of the glucagon-like peptide 1 receptor (GLP-1) for red...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cereb Blood Flow Metab
Hlavní autoři: Darsalia, Vladimer, Larsson, Martin, Nathanson, David, Klein, Thomas, Nyström, Thomas, Patrone, Cesare
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2015
Témata:
Mini Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4420864/
https://ncbi.nlm.nih.gov/pubmed/25669907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.17
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky